Anavex Life Sciences Corp (AVXL)
3.85
+0.09
(+2.39%)
USD |
NASDAQ |
May 03, 16:00
3.835
-0.02
(-0.39%)
After-Hours: 20:00
Anavex Life Sciences Price to Book Value: 2.332 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.332 |
| May 02, 2024 | 2.277 |
| May 01, 2024 | 2.235 |
| April 30, 2024 | 2.211 |
| April 29, 2024 | 2.211 |
| April 26, 2024 | 2.084 |
| April 25, 2024 | 2.053 |
| April 24, 2024 | 2.065 |
| April 23, 2024 | 2.229 |
| April 22, 2024 | 2.229 |
| April 19, 2024 | 2.289 |
| April 18, 2024 | 2.302 |
| April 17, 2024 | 2.465 |
| April 16, 2024 | 2.495 |
| April 15, 2024 | 2.562 |
| April 12, 2024 | 2.601 |
| April 11, 2024 | 2.695 |
| April 10, 2024 | 2.598 |
| April 09, 2024 | 2.659 |
| April 08, 2024 | 2.659 |
| April 05, 2024 | 2.677 |
| April 04, 2024 | 2.713 |
| April 03, 2024 | 2.798 |
| April 02, 2024 | 2.750 |
| April 01, 2024 | 3.040 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.083 |
| March 27, 2024 | 3.065 |
| March 26, 2024 | 2.931 |
| March 25, 2024 | 2.756 |
| March 22, 2024 | 2.822 |
| March 21, 2024 | 3.095 |
| March 20, 2024 | 3.101 |
| March 19, 2024 | 2.931 |
| March 18, 2024 | 2.919 |
| March 15, 2024 | 3.095 |
| March 14, 2024 | 3.113 |
| March 13, 2024 | 3.258 |
| March 12, 2024 | 3.149 |
| March 11, 2024 | 3.143 |
| March 08, 2024 | 3.301 |
| March 07, 2024 | 3.143 |
| March 06, 2024 | 3.040 |
| March 05, 2024 | 3.016 |
| March 04, 2024 | 3.095 |
| March 01, 2024 | 3.198 |
| February 29, 2024 | 3.113 |
| February 28, 2024 | 3.21 |
| February 27, 2024 | 3.228 |
| February 26, 2024 | 3.016 |
| February 23, 2024 | 2.980 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.053
Minimum
Apr 25 2024
27.57
Maximum
Jun 28 2021
7.812
Average
6.802
Median
Mar 30 2020
Price to Book Value Benchmarks
| Ventyx Biosciences Inc | 1.178 |
| Checkpoint Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
Price to Book Value Related Metrics
| Price | 3.85 |
| Earnings Yield | -14.29% |
| Market Cap | 316.13M |